Search Stock:
Beta Drugs (BETA) Key Ratios
P/E
Company57.48
Sector7.51
A Price-to-Earnings of 57.48 means investors pay 57.48 units per 1 unit of earnings. This is higher than the sector average of 7.51.
P/B
Company10.82
Sector4.33
A P/B ratio of 10.82 shows market value relative to book value. This is higher than the sector average of 4.33.
ROA
Company9.33%
Sector-17.9%
Return on Assets shows a 9.33% profit per unit of asset. This is lower than the sector average of -17.9%.
ROE
Company16.95%
Sector-3.17%
Return on Equity creates 16.95% profit per unit of equity. This is higher than the sector average of -3.17%.
ROCE
Company17.46%
Sector6.29%
ROCE indicates 17.46% operating earnings per unit of capital. This is higher than the sector average of 6.29%.
EV/EBITDA
Company28.28
Sector14.44
EV/EBITDA of 28.28 means value is 28.28 times core earnings. This is higher than the sector average of 14.44.
Beta Drugs Share Price Analysis API (Live)
Beta Drugs share price is ₹2,206.80, day high (share price) is ₹2,277.00, day low (share price) is ₹2,180.00 and volume is 12,964. 52 Week high share price for Beta Drugs is ₹2,807.90 on 12 Aug 2026 and 52 week low share price for Beta Drugs is ₹990.10 on 25 Feb 2026. Price data as of: 01 Sep, 2026 3:31 PM.
According to latest price data (as of 01 Sep, 2026 3:31 PM) for Beta Drugs share, 14 day period RSI (Relative Strength Index) is 44.0, 50 DMA (50 Displaced Moving Average) is 2,291.59 and 200 DMA (200 Displaced Moving Average) is 1,647.36.
▼
₹2,206.80
-53.10 (-2.35%)
As of 01 Sep, 2026
Open
₹2,277.00
Day High - Low
₹2,277.00 - ₹2,180.00
Volume
12,964
52 Weeks High
₹2,807.90
on 12 Aug 2026
52 Weeks Low
₹990.10
on 25 Feb 2026
RSI (14)
44.0
50 DMA
2,291.59
200 DMA
1,647.36
Loading...
Beta Drugs - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | May 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 59.10% | 59.10% | 66.73% | 64.90% |
| FII | 1.02% | 2.95% | 0.90% | 1.14% |
| DII (Other) | 6.23% | 6.01% | 0.29% | 1.90% |
| Retail & Others | 33.65% | 31.93% | 32.07% | 32.07% |
| Mutual Funds | 0.00% | 0.00% | 0.00% | 0.00% |
Beta Drugs - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 396.01 +7.38% | 54.39 -4.53% | 41.48 -2.22% |
| Mar 2025 | 368.80 +24.15% | 56.97 +16.86% | 42.42 +16.41% |
| Mar 2024 | 297.07 +30.37% | 48.75 +18.73% | 36.44 +18.62% |
| Mar 2023 | 227.86 | 41.06 | 30.72 |
Beta Drugs Share Price and Volume Historical Data
Synchronizing MarketBandhu Database...
